Drug Name |
SUVN-G3031
|
Synonyms |
LNXDUSQEXVQFGP-UHFFFAOYSA-N; UNII-65V47O9NOP; 65V47O9NOP; SCHEMBL12484542; N-[4-(1-Cyclobutyl piperidin-4-yloxy)phenyl]-2-(morpholin-4-yl)acetamide; 1394808-82-2 |
Indication |
Disease Entry |
ICD 11 |
Status |
REF |
Cognitive impairment |
6D71
|
Phase 3 |
[1] |
------------------------------------------------------------------------------------ |
|
|
|
|
Structure |
|
|
3D MOL
|
2D MOL
|
#Ro5 Violations (Lipinski): 0 |
Molecular Weight (mw) |
373.5 |
|
Logarithm of the Partition Coefficient (xlogp) |
2.3 |
Rotatable Bond Count (rotbonds) |
6 |
Hydrogen Bond Donor Count (hbonddonor) |
1 |
Hydrogen Bond Acceptor Count (hbondacc) |
5 |
Chemical Identifiers |
- Formula
- C21H31N3O3
- IUPAC Name
N-[4-(1-cyclobutylpiperidin-4-yl)oxyphenyl]-2-morpholin-4-ylacetamide
- Canonical SMILES
-
C1CC(C1)N2CCC(CC2)OC3=CC=C(C=C3)NC(=O)CN4CCOCC4
- InChI
-
InChI=1S/C21H31N3O3/c25-21(16-23-12-14-26-15-13-23)22-17-4-6-19(7-5-17)27-20-8-10-24(11-9-20)18-2-1-3-18/h4-7,18,20H,1-3,8-16H2,(H,22,25)
- InChIKey
-
LNXDUSQEXVQFGP-UHFFFAOYSA-N
|
Cross-matching ID |
- PubChem CID
- 60151477
- CAS Number
-
- DrugBank ID
-
- TTD ID
- D04KMP
|
|
|
|
|
|
|
|